BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 23911788)

  • 1. JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells.
    Nishimoto A; Kugimiya N; Hosoyama T; Enoki T; Li TS; Hamano K
    Biochem Biophys Res Commun; 2013 Aug; 438(3):513-8. PubMed ID: 23911788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells.
    Shackleford TJ; Zhang Q; Tian L; Vu TT; Korapati AL; Baumgartner AM; Le XF; Liao WS; Claret FX
    Breast Cancer Res; 2011 Jun; 13(3):R65. PubMed ID: 21689417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells.
    Hsu MC; Chang HC; Hung WC
    Endocr Relat Cancer; 2007 Sep; 14(3):655-67. PubMed ID: 17914096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer.
    Emberley ED; Niu Y; Curtis L; Troup S; Mandal SK; Myers JN; Gibson SB; Murphy LC; Watson PH
    Cancer Res; 2005 Jul; 65(13):5696-702. PubMed ID: 15994944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1.
    Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS
    Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression.
    Pan Y; Wang S; Su B; Zhou F; Zhang R; Xu T; Zhang R; Leventaki V; Drakos E; Liu W; Claret FX
    Oncogene; 2017 Feb; 36(8):1069-1079. PubMed ID: 27524414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation.
    Yang J; Chatterjee-Kishore M; Staugaitis SM; Nguyen H; Schlessinger K; Levy DE; Stark GR
    Cancer Res; 2005 Feb; 65(3):939-47. PubMed ID: 15705894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Jab1 regulates levels of endothelin type A and B receptors by promoting ubiquitination and degradation.
    Nishimoto A; Lu L; Hayashi M; Nishiya T; Horinouchi T; Miwa S
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1616-22. PubMed ID: 20034471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas.
    Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M
    Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity.
    Lue H; Thiele M; Franz J; Dahl E; Speckgens S; Leng L; Fingerle-Rowson G; Bucala R; Lüscher B; Bernhagen J
    Oncogene; 2007 Aug; 26(35):5046-59. PubMed ID: 17310986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear β-catenin expression is positively regulated by JAB1 in human colorectal cancer cells.
    Nishimoto A; Takemoto Y; Saito T; Kurazumi H; Tanaka T; Harada E; Shirasawa B; Hamano K
    Biochem Biophys Res Commun; 2020 Dec; 533(3):548-552. PubMed ID: 32977947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1.
    Tanaka Y; Kanai F; Ichimura T; Tateishi K; Asaoka Y; Guleng B; Jazag A; Ohta M; Imamura J; Ikenoue T; Ijichi H; Kawabe T; Isobe T; Omata M
    Oncogene; 2006 Jan; 25(4):633-42. PubMed ID: 16247477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adapter protein NRBP associates with Jab1 and negatively regulates AP-1 activity.
    Wang H; Sun X; Luo Y; Lin Z; Wu J
    FEBS Lett; 2006 Oct; 580(25):6015-21. PubMed ID: 17052710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3.
    Vogt M; Domoszlai T; Kleshchanok D; Lehmann S; Schmitt A; Poli V; Richtering W; Müller-Newen G
    J Cell Sci; 2011 Mar; 124(Pt 6):900-9. PubMed ID: 21325026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jun activation domain-binding protein 1 binds Smad5 and inhibits bone morphogenetic protein signaling.
    Haag J; Aigner T
    Arthritis Rheum; 2006 Dec; 54(12):3878-84. PubMed ID: 17133595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines.
    Fukumoto A; Tomoda K; Yoneda-Kato N; Nakajima Y; Kato JY
    FEBS Lett; 2006 Oct; 580(25):5836-44. PubMed ID: 17027978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAB1 enhances HAND2 transcriptional activity by regulating HAND2 DNA binding.
    Dai YS; Hao J; Bonin C; Morikawa Y; Cserjesi P
    J Neurosci Res; 2004 Jun; 76(5):613-22. PubMed ID: 15139020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ERp57 in the signaling and transcriptional activity of STAT3 in a melanoma cell line.
    Chichiarelli S; Gaucci E; Ferraro A; Grillo C; Altieri F; Cocchiola R; Arcangeli V; Turano C; Eufemi M
    Arch Biochem Biophys; 2010 Feb; 494(2):178-83. PubMed ID: 19995546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z; Bradner JE; Greenberg E; Levine R; Foster R; Mahoney J; Seiden MV
    Clin Cancer Res; 2006 Nov; 12(22):6844-52. PubMed ID: 17121906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional involvement of Daxx in gp130-mediated cell growth and survival in BaF3 cells.
    Muromoto R; Kuroda M; Togi S; Sekine Y; Nanbo A; Shimoda K; Oritani K; Matsuda T
    Eur J Immunol; 2010 Dec; 40(12):3570-80. PubMed ID: 21108476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.